Speaker Details

Speaker 1

Bibi Bielekova

Chief, Neuroimmunological Diseases Section, Laboratory of Clinical Imunology and Microbiology, National Institute of Allergy and Infectious Diseases

National Institutes of Health (NIH)

Dr. Bielekova is now a Senior Investigator with NIAID. Her laboratory is currently in the process of transitioning from NINDS to NIAID. Her office address remains the same, she can be reached by email at Bibi.Bielekova@nih.gov or phone at 240-669-2724. Dr. Bielekova received an M.D. degree in 1993 from Comenius University in Bratislava, Slovakia. After a medical internship at SUNY Downstate, Medical Center in Brooklyn and a neurology residency at Boston University, she did a 3 year postdoctoral research fellowship at the NIH/NINDS/Neuroimmunology Branch (NIB). She remained at NIB for additional 5 years as a staff physician, focusing on development of novel therapies for multiple sclerosis (MS). In 2005, she became associate professor of neurology with tenure and director of the Waddell Center for MS at University of Cincinnati. In 2008, she moved back to NINDS as an investigator. In 2018, Dr. Bielekova transferred as a Senior Investigator to NIAID. Her laboratory is studying mechanisms of immunoregulation and immune-mediated central nervous system (CNS) tissue injury in MS and other neuroimmunological diseases with a long-term goal of developing effective therapies. In addition, Dr. Bielekova is a principal investigator on several innovative protocols including adaptively-designed Phase I/II clinical trials.